Myositis-myasthenia gravis overlap syndrome complicated with myasthenia crisis and myocarditis associated with anti-programmed cell death-1 (sintilimab) therapy for lung adenocarcinoma

Immune checkpoint inhibitors (ICIs) have improved clinical outcomes with a number of advanced malignancies. However, diverse immune-related adverse events (iRAEs) occurred with the widespread use of ICIs, some of which are rarely and life-threatening. Here we report a 66-year-old patient with lung a...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Qian, Zhang, Zhong-Wei, Lin, Qiong-Hua, Shen, Li-Hua, Wang, Peng-Mei, Zhang, Shan, Fan, Ming, Zhu, Biao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154453/
https://www.ncbi.nlm.nih.gov/pubmed/32309397
http://dx.doi.org/10.21037/atm.2020.01.79

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154453/
https://www.ncbi.nlm.nih.gov/pubmed/32309397
http://dx.doi.org/10.21037/atm.2020.01.79

Ejemplares similares